https://sigrid.mynewsdesk.com/ Mynewsdesk RSS - Press releases, News, and Blog Posts. https://sigrid.mynewsdesk.com/ https://www.mynewsdesk.com/assets/graphics/logos/logo-small-9892f98564f91864075bd14001f8470f2f9bf254729c37044b4b1ac9b0db6b40.png 128 23 en 15 Fri, 20 Mar 2026 13:00:26 +0000 https://sigrid.mynewsdesk.com/blog_posts/how-sipore-r-works-step-by-step-124958?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/blog_posts/how-sipore-r-works-step-by-step-124958?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Thu, 12 Mar 2026 12:00:00 +0000 Post highlights: -What “metabolically healthy” really means -Why metabolic health affects energy, appetite, and long-term wellbeing -How modern meals can place stress on metabolism -Signs of healthy metabolic function -Simple habits that support metabolic health -How supporting steadier post-meal responses may help maintain metabolic balance https://sigrid.mynewsdesk.com/blog_posts/what-is-metabolically-healthy-124900?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/blog_posts/what-is-metabolically-healthy-124900?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Wed, 04 Mar 2026 12:00:00 +0000 https://sigrid.mynewsdesk.com/blog_posts/modern-food-systems-set-us-up-for-failure-124904?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/blog_posts/modern-food-systems-set-us-up-for-failure-124904?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Wed, 28 Jan 2026 09:00:00 +0000 Sigrid Therapeutics (Sigrid), a science-driven consumer health company developing innovative solutions for metabolic health, today announced the appointment of Claus Kjaersgaard as its new Chief Executive Officer. Claus will assume the role on 1 February 2026. https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-appoints-claus-kjaersgaard-as-chief-executive-officer-3437273?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-appoints-claus-kjaersgaard-as-chief-executive-officer-3437273?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Wed, 21 Jan 2026 08:00:00 +0000 Sigrid today announced that it has entered into an exclusive global licensing and research collaboration with a leading multinational consumer health company to expand the SiPore® technology platform into consumer oral health through a partner-led approach. https://sigrid.mynewsdesk.com/pressreleases/sigrid-enters-exclusive-global-licensing-and-research-collaboration-to-commercialize-sipore-r-in-consumer-oral-health-3443649?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-enters-exclusive-global-licensing-and-research-collaboration-to-commercialize-sipore-r-in-consumer-oral-health-3443649?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Wed, 21 Jan 2026 00:00:00 +0000 https://sigrid.mynewsdesk.com/blog_posts/sigrid-enters-exclusive-global-licensing-and-research-collaboration-to-commercialize-sipore-r-in-consumer-oriented-oral-health-125346?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/blog_posts/sigrid-enters-exclusive-global-licensing-and-research-collaboration-to-commercialize-sipore-r-in-consumer-oriented-oral-health-125346?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Wed, 07 Jan 2026 00:00:00 +0000 Sigrid, a Swedish innovation company in consumer health, today announces that the company has raised SEK 45 million in new capital. https://sigrid.mynewsdesk.com/blog_posts/sigrid-raises-sek-45-million-to-scale-up-its-groundbreaking-technology-for-metabolic-health-125347?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/blog_posts/sigrid-raises-sek-45-million-to-scale-up-its-groundbreaking-technology-for-metabolic-health-125347?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Wed, 27 Aug 2025 00:00:00 +0000 After an exceptionally successful online launch earlier this year, Sigrid Therapeutics and Kronans Apotek are now ready to take the next step: SIGRID Stabiliser will be launched on store shelves across the country in the fall of 2025. https://sigrid.mynewsdesk.com/pressreleases/sigrid-stabiliser-record-online-sales-at-kronans-apotek-lead-to-store-launch-this-fall-3443860?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-stabiliser-record-online-sales-at-kronans-apotek-lead-to-store-launch-this-fall-3443860?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Tue, 12 Aug 2025 00:00:00 +0000 Sigrid Therapeutics AB (Sigrid) announces that CEO Sana Alajmovic will leave her operational role on January 31, 2026 to take up a new position outside of Sigrid's operations and that does not compete with the company. https://sigrid.mynewsdesk.com/pressreleases/sana-alajmovic-to-leave-as-ceo-of-sigrid-therapeutics-in-early-2026-3443862?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sana-alajmovic-to-leave-as-ceo-of-sigrid-therapeutics-in-early-2026-3443862?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Mon, 09 Jun 2025 00:00:00 +0000 SIGRID, the Swedish innovative consumer health company behind the patented SiPore® technology, today reports new clinical and commercial milestones for its innovative dietary supplement Glucose Stabiliser. https://sigrid.mynewsdesk.com/pressreleases/sigrids-glucose-stabiliser-demonstrates-clinical-efficacy-and-strong-sales-growth-in-the-us-meeting-growing-global-demand-for-natural-solutions-for-metabolic-health-3443865?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrids-glucose-stabiliser-demonstrates-clinical-efficacy-and-strong-sales-growth-in-the-us-meeting-growing-global-demand-for-natural-solutions-for-metabolic-health-3443865?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Thu, 20 Mar 2025 00:00:00 +0000 Sigrid Therapeutics (Sigrid) today announced that it has secured U.S. marketing approval for its patented SiPore® technology, following the successful SHINE study, the largest study of its kind in prediabetes. https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-secures-us-market-approval-for-sipore-r-technology-following-successful-shine-prediabetes-study-3443866?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-secures-us-market-approval-for-sipore-r-technology-following-successful-shine-prediabetes-study-3443866?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Wed, 05 Feb 2025 00:00:00 +0000 Sigrid Therapeutics announces today that their innovative product, Sigrid Stabiliser, which was previously only available through the company's own e-commerce, will now be launched and offered exclusively at Kronans Apotek starting in February 2025. https://sigrid.mynewsdesk.com/pressreleases/sigrid-stabiliser-launched-at-kronans-apotek-making-preventive-health-more-accessible-3443867?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-stabiliser-launched-at-kronans-apotek-making-preventive-health-more-accessible-3443867?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Mon, 02 Sep 2024 00:00:00 +0000 Sigrid Therapeutics today announced the signing of a strategic partnership with GetHealthy.store, a leading US provider of e-commerce solutions for healthcare providers selling healthcare and nutritional products. https://sigrid.mynewsdesk.com/pressreleases/sigrid-enters-strategic-partnership-with-gethealthy-to-meet-growing-demand-in-the-us-for-glucose-stabiliser-as-a-non-pharmaceutical-solution-to-control-blood-sugar-levels-3443868?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-enters-strategic-partnership-with-gethealthy-to-meet-growing-demand-in-the-us-for-glucose-stabiliser-as-a-non-pharmaceutical-solution-to-control-blood-sugar-levels-3443868?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Tue, 30 Jul 2024 00:00:00 +0000 Sigrid Therapeutics announced today that recruitment to the SHINE clinical trial, which is evaluating the company's breakthrough product SiPore21® for long-term diabetes control, has been completed. https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-completes-recruitment-into-shine-a-study-evaluating-sipore21-r-gel-for-long-term-blood-sugar-and-weight-control-3443871?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-completes-recruitment-into-shine-a-study-evaluating-sipore21-r-gel-for-long-term-blood-sugar-and-weight-control-3443871?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Tue, 30 Apr 2024 00:00:00 +0000 Sigrid Therapeutics announced today that the company has recruited over 50% of patients in SHINE, a clinical trial evaluating SiPore21® for the treatment of elevated glucose levels. https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-surpasses-50-procent-patient-recruitment-in-its-clinical-trial-shine-evaluating-sipore21-r-for-sustainable-diabetes-and-obesity-control-3443874?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-surpasses-50-procent-patient-recruitment-in-its-clinical-trial-shine-evaluating-sipore21-r-for-sustainable-diabetes-and-obesity-control-3443874?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Tue, 14 Nov 2023 00:00:00 +0000 Sigrid Therapeutics today announced that the company has launched Glucose Stabiliser in the US. https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-launches-glucose-stabiliser-in-the-us-an-over-the-counter-dietary-supplement-designed-to-control-blood-sugar-and-body-weight-3443876?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-launches-glucose-stabiliser-in-the-us-an-over-the-counter-dietary-supplement-designed-to-control-blood-sugar-and-body-weight-3443876?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Tue, 31 Oct 2023 00:00:00 +0000 Sigrid Therapeutics has secured SEK 44 million in a successful and oversubscribed financing round, underscoring the strong confidence of investors in Sigrid's innovative SiPore technology®. https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-secures-sek-44-million-in-oversubscribed-financing-round-targeting-the-growing-market-for-the-treatment-of-obesity-and-diabetes-3443879?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-secures-sek-44-million-in-oversubscribed-financing-round-targeting-the-growing-market-for-the-treatment-of-obesity-and-diabetes-3443879?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Mon, 09 Oct 2023 00:00:00 +0000 Sigrid Therapeutics is pleased to announce the start of the SHINE clinical trial for SiPore21® – an innovative medical device designed for long-term maintenance of blood sugar and weight control. https://sigrid.mynewsdesk.com/pressreleases/first-patient-treated-in-sigrid-therapeutics-clinical-trial-shine-of-the-medical-device-sipore21-r-3443881?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/first-patient-treated-in-sigrid-therapeutics-clinical-trial-shine-of-the-medical-device-sipore21-r-3443881?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Tue, 09 May 2023 00:00:00 +0000 Sigrid Therapeutics (Sigrid), a Swedish consumer healthcare company, announced today that Professor Iain Chapple, a world-leading expert in oral health from the University of Birmingham's College of Medical and Dental Sciences, has been appointed as the company's scientific advisor. https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-appoints-professor-iain-chapple-an-international-authority-in-oral-health-to-the-companys-scientific-advisory-board-3443883?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-appoints-professor-iain-chapple-an-international-authority-in-oral-health-to-the-companys-scientific-advisory-board-3443883?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB Wed, 08 Mar 2023 00:00:00 +0000 Sigrid Therapeutics, an innovative, consumer-focused health company, today presented the results of a consumer trial ahead of the launch of their clinically proven SiPore® technology for blood sugar control in prediabetics and type 2 diabetics. https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-reports-positive-results-from-consumer-testing-of-sipore-r-a-product-intended-for-prediabetics-type-2-diabetics-and-obese-people-to-control-blood-sugar-levels-3443884?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://sigrid.mynewsdesk.com/pressreleases/sigrid-therapeutics-reports-positive-results-from-consumer-testing-of-sipore-r-a-product-intended-for-prediabetics-type-2-diabetics-and-obese-people-to-control-blood-sugar-levels-3443884?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Sigrid Therapeutics AB